Клинико-экономическое обоснование применения Ксолара (омализумаб) при бронхиальной астме (ПРОДОЛЖЕНИЕ)
Пн, 11 Фев 2008
1842

В НАЧАЛО СТАТЬИ: http://www.clinvest.ru/part.php?pid=99

Источник: Колбин А.С., Климко Н.Н., Андреев Б.В. Клинико-экономическое обоснование применения Ксолара (омализумаб) при бронхиальной астме. // Качественная клиническая практика, 2008 г., №2, стр. 53-61


Литература

  1. Ayres J.G., Higgins B., Chilvers E.R, et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma. Allergy 2004;59:701-8 
  2. Bousquet J., Cabrera P., Berkman N., et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 2005;60:302-8 
  3. Bousquet J., Rabe K., Humbert M., et al. Predicting and evaluating response to omalizumab in patients with severe persistent allergic asthma. Respir Med 2007; March 3 (Epub ahead of print) 
  4. Buhl R., Hanf G., Soler M., et al. The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. Eur Respir J 2002;20:1088-94 
  5. Buhl R., Soler M., Matz J., et al. Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma. Eur Respir J 2002; 20:73-8. 
  6. Burrows B., Martinez F.D., Halonen M., et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271-7 
  7. Chipps B., Buhl R., Beeh K.M., et al. Improvement in quality of life with omalizumab in patients with severe allergic asthma. Curr Med Res Opin 2006;22:2201-8 
  8. Corren J, Casale T, Lanier BQ, et al. Omalizumab is well tolerated in adolescent/adult patients (>12 years) with moderate-to-severe asthma. J Allergy Clin Immunol 2005; 115:S75
  9. Fuhlbrigge AL, Adams RJ, Guilbert TW, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med 2002;166:1044–9
  10. Global Initiative for Asthma. Global strategy for asthma management and prevention. NIH Publication No 02-3659 (revised 2006). National Institutes of Health/National Heart, Lung and Blood Institute
  11. Hartert TV, Speroff T, Togias A, et al. Risk factors for recurrent asthma hospital visits and death among a population of indigent older adults with asthma. Ann Allergy Asthma Immunol 2002;89: 467–73
  12. Holgate ST, Chuchalin AG, Hébert J, et al. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy 2004;34:632–8
  13. http://health-y.ru/price-tr
  14. http://pulmonolog-kb.ru/?section=7
  15. http://www.presidentclinic.ru/?section=185
  16. Humbert M, Beasley R, Ayres J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005;60:309–16
  17. Patient UK. Asthma. http://www.patient.co.uk/showdoc/23068680/
  18. Solèr M, Matz J, Townley R, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001;18:254–61
  19. Vignola AM, Humbert M, Bousquet J, et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy 2004;59:709–17
  20. Wenzel S, Beasley R, Berkman N, et al. Omalizumab is efficacious in patients with severe asthma irrespective of oral corticosteroid use. Chest 2007. In press.
  21. Zeldin R, Massanari M, Maykut R, et al. Omalizumab reduced the need for steroid bursts in asthmatics concomitantly using leukotriene receptor antagonists (LTRAs). J Allergy Clin Immunol 2006; 117:S280,1080
  22. Дрожжев М.Е., Лев Н.С. и соавт. Современные показатели распространённости бронхиальной астмы среди детей. Пульмонология, 2002 г. №2 стр.42-46
  23. Княжеская Н.П. Бронхиальная астма: некоторые аспекты диагностики и лечения. Consilium-medicum Том 3/N 12/2001
  24. Лещенко И.В. распространённость бронхиальной астмы в Свердловской области. Пульмонология, 2001 г. №2 стр.50-55
  25. Центр трудового права http://law.edu.ru/
  26. Чучалин А.Г. Бронхиальная астма. Издат. Дом «Русский врач», 2001

Похожие статьи